Combination antiretroviral therapy and the risk of myocardial infarction
Abstract:
Background It remains controversial whether exposure to combination antiretroviral treatment increases the risk of myocardial infarction. Methods In this prospective observational study, we enrolled 23,468 patients from 11 previously established cohorts from December 1999 to April 2001 and collected follow-up data until February 2002. Data were collected on infection with the human immunodeficiency virus and on risk factors for and the incidence of myocardial infarction. Relative rates were calculated with Poisson regression models. Combination antiretroviral therapy was defined as any combination regimen of antiretroviral drugs that included a protease inhibitor or a nonnucleoside reverse transcriptase inhibitor. Results Over a period of 36,199 person-years, 126 patients had a myocardial infarction. The incidence of myocardial infarction increased with longer exposure to combination antiretroviral therapy …
Año de publicación:
2003
Keywords:
Fuente:

Tipo de documento:
Other
Estado:
Acceso abierto
Áreas de conocimiento:
- Enfermedad cardiovascular
- Medicina interna
Áreas temáticas:
- Enfermedades
- Problemas sociales y servicios a grupos
- Farmacología y terapéutica